Gabapentin recalls

The FDA has published 22 recalls involving Gabapentin since 2013. The latest was reported on 29 Oct 2025. Most were for packaging defects. The Harvard Drug Group has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls22since 2013

Last 12 months2reported

Class I00% of total

Ongoing7latest 29 Oct 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 3Apr 0 0 2Jul 0 0 2Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 15 68%Class III 7 32%

Why gabapentin is recalled

Companies

Brands

Gabapentin1673%
Gaba 300-ezs15%

By year

2025732%
202415%
202329%
202115%
202029%
201915%
2018314%
2015418%
201315%

Ongoing gabapentin recalls

7 active

Reported	Class	Recall	Company	Reason	Where
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister packs) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
9 Jul 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg recalled by The Harvard Drug GroupGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
9 Jul 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg , blister pack recalledGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 300 mg recalledGabapentin	Sun Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 400 mg recalledGabapentin	Sun Pharmaceutical Industries	Packaging Defects	Nationwide

All gabapentin recalls, newest first

22 total

Reported	Class	Recall	Company	Reason	Where
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister packs) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
29 Oct 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentin	The Harvard Drug Group	Potency & Assay	Nationwide
9 Jul 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg recalled by The Harvard Drug GroupGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
9 Jul 2025Drug	CLASS II	Gabapentin Capsules, USP, 100 mg , blister pack recalledGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 300 mg recalledGabapentin	Sun Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS III	Gabapentin Capsules, USP 400 mg recalledGabapentin	Sun Pharmaceutical Industries	Packaging Defects	Nationwide
16 Apr 2025Drug	CLASS II	Gabapentin Tablets 600mg recalled by Glenmark PharmaceuticalsGabapentin	Glenmark Pharmaceuticals Inc., U	Manufacturing (CGMP) Deviations	Nationwide
14 Aug 2024Drug	CLASS II	Gabapentin Tablets, USP, 600 mg recalled by Granules PharmaceuticalsGabapentin	Granules Pharmaceuticals	Other	Nationwide
17 May 2023Drug	CLASS III	Gabapentin Tablets, USP 600 mg recalled by The Harvard Drug GroupGabapentin	The Harvard Drug Group	Packaging Defects	Nationwide
8 Mar 2023Drug	CLASS III	Gabapentin Tablets, USP 600 mg recalled by Sciegen PharmaceuticalsGabapentin	Sciegen Pharmaceuticals	Other	Nationwide

Should you stop taking Gabapentin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.